|
| Exchange Disseminated Time | With reference to the news item appearing in a leading financial daily dated February 25, 2014 titled "Pfizer Stock Gains Over 20% on Stake Recast Plans", Pfizer Ltd has clarified to BSE as under:
"1. The news article is speculative and was not authorised by, or attributable to any statements made by or on behalf of, Pfizer Limited. For instance, the article mentions unsubstantiated market rumours of a possible delisting of Pfizer Limited. Pfizer Limited is not aware of any discussions or proposals by Its promoters to delist the company’s shares from Indian markets.
2. As regards the transfer of shares of Pfizer Limited, such transaction is being undertaken directly between shareholders of Pfizer Limited and to which, Pfizer Limited was not a transacting party. Pfizer Limited understands that filings have been made by the acquiring entity i.e., Pfizer East India B.V., Netherlands, under applicable provisions of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. We understand that such transfers are being undertaken as part of the global internal corporate restructuring plan of the Pfizer Group, as reported by us previously. We do not believe that the present transfers have bearing on the stack price of Pfizer Limited, given especially that ultimate control of Pfizer Limited remains unchanged.
3. While we are not aware of the reasons behind the price movement, it could possibly be a result of the filings made by Pfizer East India B.V., Netherlands, under the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
4. Rest assured, if and when we make any announcement regarding any material activity for our business, we will ensure that we continue to follow mandated procedures of informing stock exchanges in a timely manner, so as to ensure uniform and simultaneous disclosure to all the investors." |
|
|